COST-EFFECTIVENESS ANALYSIS OF RALTEGRAVIR IN HIV-INFECTED TREATMENT NAIVE PATIENTS IN GREECE

被引：1
|
作者：
Athanasakis, K. [1 ]
Boubouchairopoulou, N. [1 ]
Retsa, M. P. [2 ]
Maiese, E. M. [3 ]
Elbasha, E. H. [4 ]
Kyriopoulos, J. [1 ]
机构：
[1] Natl Sch Publ Hlth, Athens, Greece
[2] MSD Hellas, Athens, Greece
[3] Merck & Co Inc, Whitehouse Stn, NJ USA
[4] Merck & Co Inc, Flourtown, PA USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2506
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN65
引用
收藏
页码：A675 / A675
页数：1
相关论文
共 50 条
  • [21] The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia
    Ryan, Mairin
    Griffin, Susan
    Chitah, Bona
    Walker, A. Sarah
    Mulenga, Veronica
    Kalolo, Donald
    Hawkins, Neil
    Merry, Concepta
    Barry, Michael G.
    Chintu, Chifumbe
    Sculpher, Mark J.
    Gibb, Diana M.
    [J]. AIDS, 2008, 22 (06) : 749 - 757
  • [22] Cost-effectiveness of dolutegravir vs. efavirenz-based combined antiretroviral therapies in HIV-infected treatment-naive patients in a Nigerian treatment centre
    Isah, Abdulmuminu
    Chukwu, Patrick O.
    Abba, Abubakar
    Igboeli, Nneka U.
    Ebere, Ayogu
    Omotola, Olusegun F.
    Alozie, Faith A.
    Ekwunife, Obinna, I
    Adibe, Maxwell O.
    [J]. AFRICAN HEALTH SCIENCES, 2023, 23 (01) : 157 - 169
  • [23] A microsimulation of the cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individuals
    Chancellor, J., V
    Kuehne, F. C.
    Mollon, P.
    Louie, M.
    Powderly, M. G.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A24 - A25
  • [24] Cost-Effectiveness of Maraviroc for Antiretroviral Treatment-Experienced HIV-infected Individuals in Mexico
    Contreras-Hernandez, Iris
    Becker, Debbie
    Chancellor, Jeremy
    Kuehne, Felicitas
    Mould-Quevedo, Joaquin
    Vega, Gabriela
    Marfatia, Shalaka
    [J]. VALUE IN HEALTH, 2010, 13 (08) : 903 - 914
  • [25] OPTIMAL MANAGEMENT STRATEGIES FOR HIV-INFECTED PATIENTS WHO PRESENT WITH COUGH OR DYSPNEA - A COST-EFFECTIVENESS ANALYSIS
    FREEDBERG, KA
    TOSTESON, ANA
    COTTON, DJ
    GOLDMAN, L
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 1992, 7 (03) : 261 - 272
  • [26] A Microsimulation of the Cost-effectiveness of Maraviroc for Antiretroviral Treatment-Experienced HIV-Infected Individuals
    Kuehne, Felicitas C.
    Chancellor, Jeremy
    Mollon, Patrick
    Myers, Daniela E.
    Louie, Michael
    Powderly, William G.
    [J]. HIV CLINICAL TRIALS, 2010, 11 (02): : 80 - 99
  • [27] Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patients
    Buti, M
    Wong, J
    Casado, MA
    Esteban, R
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S60 - S64
  • [28] The effectiveness of psychiatric treatment for HIV-infected patients
    Lyketsos, CG
    Fishman, M
    Schwartz, J
    Treisman, GJ
    [J]. PSYCHOSOMATICS, 1997, 38 (02) : 30 - 30
  • [29] The effectiveness of psychiatric treatment for HIV-infected patients
    Lyketsos, CG
    Fishman, M
    Hutton, H
    Cox, T
    Hobbs, S
    Spoler, C
    Hunt, W
    Driscoll, J
    Treisman, G
    [J]. PSYCHOSOMATICS, 1997, 38 (05) : 423 - 432
  • [30] Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa
    Miot, Jacqui
    Leong, Trudy
    Takuva, Simbarashe
    Parrish, Andrew
    Dawood, Halima
    [J]. BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)
12345